IAG and Claris Ventures announce a new strategic collaboration in the life sciences sector. This synergy was created with the aim of strengthening the Italian biotech innovation ecosystem, promoting the development of start-ups in the pre-seed and seed stage.
The collaboration is part of a context of strengthening the link between IAG and Claris, recently intensified at the launch of the Turin team’s second fund. The two entities have already collaborated successfully through several co-investments, consolidating a relationship based on trust, complementarity and concrete results.
Emanuele Torlonia, managing director of Italian Angels for Growth comments in a note: “This collaboration with Claris Ventures represents a fundamental step for IAG in our strategy of strengthening the Italian biotech ecosystem. Combining our expertise and our network with Claris’ experience in company building and in the selection of high-potential clinical projects allows us to intercept and concretely support start-ups in the most delicate phase of their journey”.
Carlo Tassi, President of Italian Angels for Growth adds: ‘Since its inception, IAG has always had a strong focus on the life sciences and in recent years its members have mainly invested in the biotech sector by co-investing on several occasions with the Claris Biotech I fund. The partnership with Claris represents a fundamental step for IAG in its mission to bring value to its shareholders by collaborating with the best players in the Italian ecosystem”.
Pietro Puglisi and Ciro Spedaliere, managing partners of Claris Ventures, also emphasise the importance of this partnership in light of the fact that Claris Ventures recently announced the closing of its second fund as we wrote here.
This partnership represents a further step towards structured joint growth, which will enhance scouting, evaluation and support opportunities for start-ups, with a focus on Italian projects with high scientific and technological content.
ALL RIGHTS RESERVED ©